Evanthia Galanis, MD
Evanthia Galanis, MD
Professor of Medical Oncology, Mayo College of Medicine
Adresse e-mail validée de mayo.edu
Citée par
Citée par
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ...
Journal of clinical oncology 28 (11), 1963-1972, 2010
Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial
PD Brown, K Jaeckle, KV Ballman, E Farace, JH Cerhan, SK Anderson, ...
Jama 316 (4), 401-409, 2016
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study
E Galanis, JC Buckner, MJ Maurer, JI Kreisberg, K Ballman, J Boni, ...
Journal of Clinical Oncology 23 (23), 5294-5304, 2005
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre, randomised, controlled …
PD Brown, KV Ballman, JH Cerhan, SK Anderson, XW Carrero, ...
The Lancet Oncology 18 (8), 1049-1060, 2017
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
TC Liu, E Galanis, D Kirn
Nature clinical practice Oncology 4 (2), 101-117, 2007
Extrapulmonary small cell carcinoma
E Galanis, S Frytak, RV Lloyd
Cancer: Interdisciplinary International Journal of the American Cancer …, 1997
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints
T Reid, E Galanis, J Abbruzzese, D Sze, LM Wein, J Andrews, B Randlev, ...
Cancer research 62 (21), 6070-6079, 2002
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
A Grothey, E Galanis
Nature reviews Clinical oncology 6 (9), 507-518, 2009
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini, JN Sarkaria, A Saito, JH Uhm, E Galanis, BL Carlson, ...
Neuro-oncology 7 (2), 164-176, 2005
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ...
Journal of clinical oncology 27 (12), 2052, 2009
Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials
BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ...
Neuro-oncology 17 (9), 1188-1198, 2015
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial
T Reid, E Galanis, J Abbruzzese, D Sze, J Andrews, L Romel, M Hatfield, ...
Gene therapy 8 (21), 1618-1626, 2001
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer
E Galanis, LC Hartmann, WA Cliby, HJ Long, PP Peethambaram, ...
Cancer research 70 (3), 875-882, 2010
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme
LK Phuong, C Allen, KW Peng, C Giannini, S Greiner, CJ TenEyck, ...
Cancer research 63 (10), 2462-2469, 2003
Intraperitoneal therapy of ovarian cancer using an engineered measles virus
KW Peng, CJ TenEyck, E Galanis, KR Kalli, LC Hartmann, SJ Russell
Cancer research 62 (16), 4656-4662, 2002
Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
JN Sarkaria, LS Hu, IF Parney, DH Pafundi, DH Brinkmann, NN Laack, ...
Neuro-oncology 20 (2), 184-191, 2018
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results
E Galanis, JC Buckner, RP Dinapoli, BW Scheithauer, RB Jenkins, ...
Journal of neurosurgery 89 (3), 425-430, 1998
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
JN Sarkaria, L Yang, PT Grogan, GJ Kitange, BL Carlson, MA Schroeder, ...
Molecular cancer therapeutics 6 (3), 1167-1174, 2007
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
E Galanis, SH Okuno, AG Nascimento, BD Lewis, RA Lee, AM Oliveira, ...
Gene therapy 12 (5), 437-445, 2005
Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
EK Mader, Y Maeyama, Y Lin, GW Butler, HM Russell, E Galanis, ...
Clinical Cancer Research 15 (23), 7246-7255, 2009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20